BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, Daar E, Cercek B. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003;163:457-460. [PMID: 12588205 DOI: 10.1001/archinte.163.4.457] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Seecheran VK, Giddings SL, Seecheran NA. Acute coronary syndromes in patients with HIV. Coron Artery Dis 2017;28:166-72. [PMID: 27845996 DOI: 10.1097/MCA.0000000000000450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
3 Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome. J Am Heart Assoc 2020;9:e017578. [PMID: 32844734 DOI: 10.1161/JAHA.119.017578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pearce D, Ani C, Espinosa-Silva Y, Clark R, Fatima K, Rahman M, Diebolt E, Ovbiagele B. Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals. Am J Cardiol 2012;110:1078-84. [PMID: 22762716 DOI: 10.1016/j.amjcard.2012.05.045] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
5 Mavroudis CA, Majumder B, Loizides S, Christophides T, Johnson M, Rakhit RD. Coronary artery disease and HIV; getting to the HAART of the matter. International Journal of Cardiology 2013;167:1147-53. [DOI: 10.1016/j.ijcard.2012.09.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
6 Jericó C, Knobel H, Carmona A, Luisa Sorli M, Luis López-colomés J, Pedro-botet J. Enfermedad cardiovascular sintomática en pacientes infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral de gran actividad. Medicina Clínica 2004;122:298-300. [DOI: 10.1016/s0025-7753(04)74214-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Peyracchia M, De Lio G, Montrucchio C, Omedè P, d'Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D'Ascenzo F. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study. Atherosclerosis 2018;274:218-26. [PMID: 29803160 DOI: 10.1016/j.atherosclerosis.2018.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
8 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
9 Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol 2012;18:247-55. [PMID: 22205585 DOI: 10.1007/s13365-011-0073-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
10 Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006;20:2275-83. [PMID: 17117013 DOI: 10.1097/QAD.0b013e3280108704] [Cited by in Crossref: 213] [Cited by in F6Publishing: 134] [Article Influence: 13.3] [Reference Citation Analysis]
11 Mishra RK. Cardiac emergencies in patients with HIV. Emerg Med Clin North Am 2010;28:273-82, Table of Contents. [PMID: 20413011 DOI: 10.1016/j.emc.2010.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV; American College of Cardiology Foundation. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:3097-3137. [PMID: 23182125 DOI: 10.1016/j.jacc.2012.07.013] [Cited by in Crossref: 1037] [Cited by in F6Publishing: 792] [Article Influence: 103.7] [Reference Citation Analysis]
13 Barros ZM, de Alencar Ximenes RA, Miranda-Filho DB, de Albuquerque Mde F, Melo HR, Carvalho EH, Gelenske T, Diniz G, Bandeira F. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil. Metab Syndr Relat Disord 2010;8:489-97. [PMID: 20973693 DOI: 10.1089/met.2009.0100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
14 Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS 2008;22 Suppl 3:S19-26. [PMID: 18845918 DOI: 10.1097/01.aids.0000327512.76126.6e] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
15 Stöllberger C, Armbruster C, Gmeinhart B, Finsterer J. Thrombosis of a drug-eluting stent after almost 2 years in an HIV-infected patient. AIDS 2007;21:1064-6. [PMID: 17457111 DOI: 10.1097/QAD.0b013e3280f6ceb9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Dau B, Holodniy M. The Relationship Between HIV Infection and Cardiovascular Disease. Curr Cardiol Rev 2008;4:203-18. [PMID: 19936197 DOI: 10.2174/157340308785160589] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
17 Marsousi N, Daali Y, Fontana P, Reny JL, Ancrenaz-Sirot V, Calmy A, Rudaz S, Desmeules JA, Samer CF. Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. Clin Pharmacokinet 2018;57:1347-54. [PMID: 29453687 DOI: 10.1007/s40262-018-0637-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
18 Rimland D, Guest JL, Hernández-ramos I, del Rio C, Le NA, Brown WV. Antiretroviral Therapy in HIV-Positive Women Is Associated With Increased Apolipoproteins and Total Cholesterol. JAIDS Journal of Acquired Immune Deficiency Syndromes 2006;42:307-13. [DOI: 10.1097/01.qai.0000220164.72113.12] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
19 Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006;185:1-11. [PMID: 16297390 DOI: 10.1016/j.atherosclerosis.2005.09.025] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
20 Hsue PY, Waters DD. What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection. Circulation 2005;112:3947-57. [DOI: 10.1161/circulationaha.105.546465] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
21 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
22 Glazier JJ, Spears JR, Murphy MC. Interventional approach to recurrent myocardial infarction in HIV-1 infection. J Interv Cardiol 2006;19:93-8. [PMID: 16483347 DOI: 10.1111/j.1540-8183.2006.00111.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
23 Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32:41-50. [PMID: 20965887 DOI: 10.1093/eurheartj/ehq372] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
24 Cerrato E, Calcagno A, D'Ascenzo F, Biondi-Zoccai G, Mancone M, Grosso Marra W, Demarie D, Omedè P, Abbate A, Bonora S, DiNicolantonio JJ, Estrada V, Escaned J, Moretti C, Gaita F. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015;2:e000174. [PMID: 25815207 DOI: 10.1136/openhrt-2014-000174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
25 Hatleberg CI, Ryom L, El-Sadr W, Smith C, Weber R, Reiss P, Fontas E, Dabis F, Law M, Monforte Ad, De Wit S, Mocroft A, Phillips A, Lundgren JD, Sabin C; D:A:D Study Group. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS 2016;30:1583-96. [PMID: 26950315 DOI: 10.1097/QAD.0000000000001076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, Schietroma I, Serafino S, Giustini N, Vullo V. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther 2016;13:21. [PMID: 27127532 DOI: 10.1186/s12981-016-0105-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
27 Vallabhajosyula S, Subramaniam AV, Sundaragiri PR, Cheungpasitporn W, Temesgen Z, O'Horo JC, Jaffe AS, Barsness GW. Influence of Human Immunodeficiency Virus Infection on the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock. J Acquir Immune Defic Syndr 2020;85:331-9. [PMID: 32740372 DOI: 10.1097/QAI.0000000000002442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Knudsen A, Mathiasen AB, Worck RH, Kastrup J, Gerstoft J, Katzenstein TL, Kjaer A, Lebech AM. Angiographic features and cardiovascular risk factors in human immunodeficiency virus-infected patients with first-time acute coronary syndrome. Am J Cardiol 2013;111:63-7. [PMID: 23040592 DOI: 10.1016/j.amjcard.2012.08.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
29 Ceccarelli G, d'Ettorre G, Mancone M, Francone M, Vullo V. Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature. Cardiovasc Revasc Med 2011;12:262-5. [PMID: 21273145 DOI: 10.1016/j.carrev.2010.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
30 D'Ascenzo F, Cerrato E, Appleton D, Moretti C, Calcagno A, Abouzaki N, Vetrovec G, Lhermusier T, Carrie D, Das Neves B, Escaned J, Cassese S, Kastrati A, Chinaglia A, Belli R, Capodanno D, Tamburino C, Santilli F, Parodi G, Vachiat A, Manga P, Vignali L, Mancone M, Sardella G, Fedele F, DiNicolantonio JJ, Omedè P, Bonora S, Gaita F, Abbate A, Zoccai GB; Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study Investigators. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. Thromb Res 2014;134:558-64. [PMID: 25064035 DOI: 10.1016/j.thromres.2014.05.037] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
31 Triant VA, Grinspoon SK. Vascular dysfunction and cardiovascular complications. Curr Opin HIV AIDS 2007;2:299-304. [PMID: 19372902 DOI: 10.1097/COH.0b013e3281e7e831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354-e471. [PMID: 23166211 DOI: 10.1161/cir.0b013e318277d6a0] [Cited by in Crossref: 338] [Cited by in F6Publishing: 225] [Article Influence: 33.8] [Reference Citation Analysis]
33 Lima GSD, Cavalcante TDMC, Isabella APJ, Magalhães ADS. Assistência de enfermagem a um paciente infartado portador de HIV, baseada na teoria do autocuidado: estudo de caso. Acta paul enferm 2007;20:452-7. [DOI: 10.1590/s0103-21002007000400011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Boccara F, Ederhy S, Janower S, Benyounes N, Odi G, Cohen A. Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy. HIV Med 2005;6:240-4. [PMID: 16011528 DOI: 10.1111/j.1468-1293.2005.00283.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
35 Varriale P, Saravi G, Hernandez E, Carbon F. Acute myocardial infarction in patients infected with human immunodeficiency virus. Am Heart J 2004;147:55-9. [PMID: 14691419 DOI: 10.1016/j.ahj.2003.07.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
36 Glesby MJ. Coronary heart disease in HIV-infected patients. Curr HIV/AIDS Rep 2005;2:68-73. [PMID: 16091251 DOI: 10.1007/s11904-005-0021-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
37 Conte AH, Esmailian F, LaBounty T, Lubin L, Hardy WD, Yumul R. The patient with the human immunodeficiency virus-1 in the cardiovascular operative setting. J Cardiothorac Vasc Anesth 2013;27:135-55. [PMID: 22920840 DOI: 10.1053/j.jvca.2012.06.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
38 Maisa A, Westhorpe C, Elliott J, Jaworowski A, Hearps AC, Dart AM, Hoy J, Crowe SM. Premature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virus. HIV Therapy 2010;4:675-92. [DOI: 10.2217/hiv.10.53] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
39 Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol 2019;16:745-59. [PMID: 31182833 DOI: 10.1038/s41569-019-0219-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
40 Perelló R, Calvo M, Miró O, Castañeda M, Saubí N, Camón S, Foix A, Gatell JM, Masotti M, Mallolas J, Sánchez M, Martinez E. Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohort. Eur J Intern Med 2011;22:485-8. [PMID: 21925057 DOI: 10.1016/j.ejim.2011.02.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
41 Bloomfield GS, Leung C. Cardiac Disease Associated with Human Immunodeficiency Virus Infection. Cardiol Clin 2017;35:59-70. [PMID: 27886790 DOI: 10.1016/j.ccl.2016.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
42 Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, Azzalini L. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol 2018;265:195-203. [PMID: 29885686 DOI: 10.1016/j.ijcard.2018.03.137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
43 Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523. [PMID: 23369416 DOI: 10.1016/j.jacc.2012.06.063] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
44 Dakin CL, O'Connor CA, Patsdaughter CA. HAART to heart: HIV-related cardiomyopathy and other cardiovascular complications. AACN Clin Issues 2006;17:18-29; quiz 88-90. [PMID: 16462405 DOI: 10.1097/00044067-200601000-00003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
45 Bethuyne N, Lacor P, Goldstein JP, Deuvaert FE. Coronary artery bypass grafting in a patient with HIV. HIV Med 2005;6:47-50. [PMID: 15670253 DOI: 10.1111/j.1468-1293.2005.00258.x] [Reference Citation Analysis]
46 Kamin DS, Grinspoon SK. Cardiovascular disease in HIV-positive patients. AIDS 2005;19:641-52. [PMID: 15821390 DOI: 10.1097/01.aids.0000166087.08822.bc] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
47 Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus. Vasc Health Risk Manag 2015;11:35-48. [PMID: 25609975 DOI: 10.2147/VHRM.S65885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
48 Carballo D, Delhumeau C, Carballo S, Bähler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A; Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015;12:4. [PMID: 25705241 DOI: 10.1186/s12981-015-0045-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
49 Lang S, Boccara F, Mary-krause M, Cohen A. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries. Archives of Cardiovascular Diseases 2015;108:206-15. [DOI: 10.1016/j.acvd.2015.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
50 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
51 McCutcheon K, Triantafyllis AS, Van den Eynde J, Oosterlinck W, Vachiat A, Tsabedze N, Zachariah D, Manga P, Bennett J. Coronary revascularization in patients with HIV. Trends Cardiovasc Med 2021:S1050-1738(21)00027-X. [PMID: 33626383 DOI: 10.1016/j.tcm.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Marcus JL, Hurley LB, Prasad A, Zaroff J, Klein DB, Horberg MA, Go AS, DeLorenze GN, Quesenberry CP Jr, Sidney S, Lo JC, Silverberg MJ. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med 2019;20:19-26. [PMID: 30178911 DOI: 10.1111/hiv.12670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
53 Loonam CR, Mullen A. Nutrition and the HIV-associated lipodystrophy syndrome. Nutr Res Rev. 2012;25:267-287. [PMID: 23174511 DOI: 10.1017/s0954422411000138] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
54 Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients: Analysis of Data From a French Nationwide Hospital Medical Information Database. Circulation 2013;127:1767-74. [DOI: 10.1161/circulationaha.113.001874] [Cited by in Crossref: 85] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
55 Dronda F. Riesgo vascular en pacientes con infección crónica por el VIH-1: controversias con implicaciones terapéuticas, clínicas y pronósticas. Enfermedades Infecciosas y Microbiología Clínica 2004;22:40-5. [DOI: 10.1016/s0213-005x(04)73029-3] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
56 Boccara F. Acute coronary syndrome in HIV-infected patients. Does it differ from that in the general population? Arch Cardiovasc Dis 2010;103:567-9. [PMID: 21147440 DOI: 10.1016/j.acvd.2010.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
57 Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus: PCI in Patients with HIV. Cathet Cardiovasc Intervent 2015;85:192-8. [DOI: 10.1002/ccd.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
58 Boccara F, Teiger E, Cohen A, Ederhy S, Janower S, Odi G, Di Angelantonio E, Barbarini G, Barbaro G. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart. 2006;92:543-544. [PMID: 16537777 DOI: 10.1136/hrt.2005.068445] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
59 Postigo A, Díez-Delhoyo F, Devesa C, Bruña V, Clavero-Olmos M, Vicent L, Juárez M, Sousa I, Fernández-Avilés F, Martínez-Sellés M. Clinical profile, anatomical features and long-term outcome of acute coronary syndromes in human immunodeficiency virus-infected patients. Intern Med J 2020;50:1518-23. [PMID: 31908110 DOI: 10.1111/imj.14744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
60 Barbaro G, Lorenzo GD, Cirelli A, Grisorio B, Lucchini A, Hazra C, Barbarini G. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy. Clinical Therapeutics 2003;25:2405-18. [DOI: 10.1016/s0149-2918(03)80283-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
61 Rasmussen LD, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Obel N. Mortality after myocardial infarction in HIV-infected patients who have initiated HAART. AIDS 2007;21:873-5. [PMID: 17415045 DOI: 10.1097/QAD.0b013e3280b07dc6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes 2021;7:273-9. [PMID: 33226071 DOI: 10.1093/ehjqcco/qcaa088] [Reference Citation Analysis]
63 Segev A, Cantor WJ, Strauss BH. Outcome of percutaneous coronary intervention in HIV-infected patients. Catheter Cardiovasc Interv. 2006;68:879-881. [PMID: 17086530 DOI: 10.1002/ccd.20774] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
64 Khunnawat C, Mukerji S, Havlichek D Jr, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol 2008;102:635-42. [PMID: 18721528 DOI: 10.1016/j.amjcard.2008.04.035] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
65 Becker AC, Sliwa K, Stewart S, Libhaber E, Essop AR, Zambakides CA, Essop MR. Acute coronary syndromes in treatment-naïve black South africans with human immunodeficiency virus infection. J Interv Cardiol 2010;23:70-7. [PMID: 20015160 DOI: 10.1111/j.1540-8183.2009.00520.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
66 Micieli E, Dentali F, Giola M, Grossi P, Venco A, Ageno W. Venous and arterial thrombosis in patients with HIV infection. Blood Coagulation & Fibrinolysis 2007;18:259-63. [DOI: 10.1097/mbc.0b013e32808738a3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
67 D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33:875-880. [PMID: 22187508 DOI: 10.1093/eurheartj/ehr456] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
68 Seecheran R, Seecheran V, Persad S, Dookie T, Seecheran NA. Atypical presentation of critical left main disease in an HIV-infected patient. Int Med Case Rep J 2018;11:139-43. [PMID: 29950906 DOI: 10.2147/IMCRJ.S164642] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Rimland D, Guest JL, Hernández I, Del Rio C, Le NA, Brown WV. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins. HIV Med 2005;6:326-33. [PMID: 16156880 DOI: 10.1111/j.1468-1293.2005.00316.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]